why choose us

First received: February 11, 2024

Clinical Trial: Pentoxifylline as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia; A New Perspective of an Old Drug

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pentoxifylline as an Adjunct Therapy in the Treatment of Pneumonia

Study Type: INTERVENTIONAL


Official Title: Pentoxifylline as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia; A New Perspective of an Old Drug

Brief Summary: Pentoxifylline is a xanthine-derived, commercially produced drug approved for the management of intermittent claudication in patients suffering from a chronic occlusive arterial disease of the limbs.Pentoxifylline has been documented to display anti-inflammatory and immunomodulatory effects, as well as some antithrombotic and antiviral effects.This drug has also been shown to reduce lung fibrosis in patients with COVID-19, as well as to prevent thromboembolic events.This work aims to assess the benefit of oral…

Read more